Search filters

List of works by Barbara C Vanderhyden

Context specificity of the EMT transcriptional response

scientific article published on 01 May 2020

In vivo modeling of metastatic human high-grade serous ovarian cancer in mice

scientific article published on 04 June 2020

LY75 Suppression in Mesenchymal Epithelial Ovarian Cancer Cells Generates a Stable Hybrid EOC Cellular Phenotype, Associated with Enhanced Tumor Initiation, Spreading and Resistance to Treatment in Orthotopic Xenograft Mouse Model

scientific article published on 15 July 2020

Loss of the Ste20-like kinase induces a basal/stem-like phenotype in HER2-positive breast cancers

scientific article published on 11 May 2020

Metformin Abrogates Age-Associated Ovarian Fibrosis

scientific article published on 09 October 2019

Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics.

scientific article

Publisher Correction: RIPK1 gene variants associate with obesity in humans and can be therapeutically silenced to reduce obesity in mice

scientific article published on 08 October 2020

RIPK1 gene variants associate with obesity in humans and can be therapeutically silenced to reduce obesity in mice

scientific article published on 28 September 2020

Single cell transcriptomic analysis of murine lung development on hyperoxia-induced damage

scientific article published on 10 March 2021

The Tumor Microenvironment of Epithelial Ovarian Cancer and Its Influence on Response to Immunotherapy

scientific article published on 24 July 2018

The polypeptide GALNT6 Displays Redundant Functions upon Suppression of its Closest Homolog GALNT3 in Mediating Aberrant O-Glycosylation, Associated with Ovarian Cancer Progression ⬇️

scientific article published on 08 May 2019

The strategic combination of trastuzumab emtansine with oncolytic rhabdoviruses leads to therapeutic synergy

scientific article published on 22 May 2020

Transcriptional heterogeneity of stemness phenotypes in the ovarian epithelium

scientific article published on 05 May 2021

VIVA1: a more invasive subclone of MDA-MB-134VI invasive lobular carcinoma cells with increased metastatic potential in xenograft models

scientific article published in 2022

Paulina is supported by:

About Paulina

Help